New pharmaceutical target reverses osteoporosis in mice: Duke researchers show that activating the adenosine receptor A2B not only halts but reverses bone deterioration in mouse models of osteoporosis

New pharmaceutical target reverses osteoporosis in mice: Duke researchers show that activating the adenosine receptor A2B not only halts but reverses bone deterioration in mouse models of osteoporosis: https://ift.tt/2HjsqkS Read more... https://ift.tt/33L7uND